What is the Rhythm Biosciences (ASX: RHY) share price?
The RHY share price is $0.10, down 9.09% for the day, based on the latest available ASX market data.
What is Rhythm Biosciences's market capitalisation?
Rhythm Biosciences has a market capitalisation of $35.4M, making it the 1110th-largest security listed on the ASX.
Does Rhythm Biosciences pay a dividend?
RHY does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Rhythm Biosciences profitable?
In its most recent reported period (ending 31 Dec 2025), RHY reported revenue of $46,247 and a net loss of $2.3M.
How many RHY shares are on issue?
Rhythm Biosciences has approximately 353,866,860 shares on issue, based on its market capitalisation of $35.4M and current share price.
What sector is Rhythm Biosciences in?
Rhythm Biosciences is classified in the Healthcare sector, within the Medical - Diagnostics & Research industry on the ASX.
When did Rhythm Biosciences list on the ASX?
Rhythm Biosciences listed on the Australian Securities Exchange on 6 Dec 2017.
